Hartsough EJ - Search Results

1

Mcl-1 mediates intrinsic resistance to RAF inhibitors in mutant BRAF papillary thyroid carcinoma.

Cavallo MR, Yo JC, Gallant KC, Cunanan CJ, Amirfallah A, Daniali M, Sanders AB, Aplin AE, Pribitkin EA, Hartsough EJ. Cavallo MR, et al. Among authors: hartsough ej. Cell Death Discov. 2024 Apr 15;10(1):175. doi: 10.1038/s41420-024-01945-0. Cell Death Discov. 2024. PMID: 38622136 Free PMC article.

2

Multi-omics Profiling Shows BAP1 Loss Is Associated with Upregulated Cell Adhesion Molecules in Uveal Melanoma.

Baqai U, Purwin TJ, Bechtel N, Chua V, Han A, Hartsough EJ, Kuznetsoff JN, Harbour JW, Aplin AE. Baqai U, et al. Among authors: hartsough ej. Mol Cancer Res. 2022 Aug 5;20(8):1260-1271. doi: 10.1158/1541-7786.MCR-21-0657. Mol Cancer Res. 2022. PMID: 35426938 Free PMC article.

3

An Ex Vivo Brain Slice Model to Study and Target Breast Cancer Brain Metastatic Tumor Growth.

Ciraku L, Moeller RA, Esquea EM, Gocal WA, Hartsough EJ, Simone NL, Jackson JG, Reginato MJ. Ciraku L, et al. Among authors: hartsough ej. J Vis Exp. 2021 Sep 22;(175):10.3791/62617. doi: 10.3791/62617. J Vis Exp. 2021. PMID: 34633392 Free PMC article.

4

Cell Adhesion Molecules in Plasticity and Metastasis.

Smart JA, Oleksak JE, Hartsough EJ. Smart JA, et al. Among authors: hartsough ej. Mol Cancer Res. 2021 Jan;19(1):25-37. doi: 10.1158/1541-7786.MCR-20-0595. Epub 2020 Oct 1. Mol Cancer Res. 2021. PMID: 33004622 Free PMC article. Review.

5

Mutant BRAF and MEK Inhibitors Regulate the Tumor Immune Microenvironment via Pyroptosis.

Erkes DA, Cai W, Sanchez IM, Purwin TJ, Rogers C, Field CO, Berger AC, Hartsough EJ, Rodeck U, Alnemri ES, Aplin AE. Erkes DA, et al. Among authors: hartsough ej. Cancer Discov. 2020 Feb;10(2):254-269. doi: 10.1158/2159-8290.CD-19-0672. Epub 2019 Dec 3. Cancer Discov. 2020. PMID: 31796433 Free PMC article.

6

The next-generation BET inhibitor, PLX51107, delays melanoma growth in a CD8-mediated manner.

Erkes DA, Field CO, Capparelli C, Tiago M, Purwin TJ, Chervoneva I, Berger AC, Hartsough EJ, Villanueva J, Aplin AE. Erkes DA, et al. Among authors: hartsough ej. Pigment Cell Melanoma Res. 2019 Sep;32(5):687-696. doi: 10.1111/pcmr.12788. Epub 2019 May 20. Pigment Cell Melanoma Res. 2019. PMID: 31063649 Free PMC article.

7

CADM1 is a TWIST1-regulated suppressor of invasion and survival.

Hartsough EJ, Weiss MB, Heilman SA, Purwin TJ, Kugel CH 3rd, Rosenbaum SR, Erkes DA, Tiago M, HooKim K, Chervoneva I, Aplin AE. Hartsough EJ, et al. Cell Death Dis. 2019 Mar 25;10(4):281. doi: 10.1038/s41419-019-1515-3. Cell Death Dis. 2019. PMID: 30911007 Free PMC article.

8

BRAF Splice Variant Resistance to RAF Inhibitor Requires Enhanced MEK Association.

Vido MJ, Le K, Hartsough EJ, Aplin AE. Vido MJ, et al. Among authors: hartsough ej. Cell Rep. 2018 Nov 6;25(6):1501-1510.e3. doi: 10.1016/j.celrep.2018.10.049. Cell Rep. 2018. PMID: 30404005 Free PMC article.

9

Response and Resistance to Paradox-Breaking BRAF Inhibitor in Melanomas In Vivo and Ex Vivo.

Hartsough EJ, Kugel CH 3rd, Vido MJ, Berger AC, Purwin TJ, Goldberg A, Davies MA, Schiewer MJ, Knudsen KE, Bollag G, Aplin AE. Hartsough EJ, et al. Mol Cancer Ther. 2018 Jan;17(1):84-95. doi: 10.1158/1535-7163.MCT-17-0705. Epub 2017 Nov 13. Mol Cancer Ther. 2018. PMID: 29133617 Free PMC article.

10

αC IN, αC OUT-that's what it's all about.

Hartsough EJ, Vido MJ. Hartsough EJ, et al. Pigment Cell Melanoma Res. 2017 Mar;30(2):177-178. doi: 10.1111/pcmr.12549. Epub 2016 Nov 30. Pigment Cell Melanoma Res. 2017. PMID: 27801548 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

17 results

Search Page